52 results
S-3ASR
EX-4.7
IMNM
Immunome, Inc.
8 Oct 24
Automatic shelf registration
4:31pm
Authority in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation
8-K
EX-99.2
sfgd7uhdvbs
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
ikobl6
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.4
s8grhxp
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.3
eguj2 rzc93tdjt05
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
030m7d
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
425
d39ai3t ytjc
21 Sep 23
Business combination disclosure
4:03pm
8-K
g2v1jsk
21 Sep 23
Other Events
4:01pm
424B3
09t11kmbh
28 Aug 23
Prospectus supplement
9:10am
S-4/A
7yme3gffwi2rjqr
25 Aug 23
Registration of securities issued in business combination transactions (amended)
6:38am
S-4
gsdwu40j02bkq
8 Aug 23
Registration of securities issued in business combination transactions
4:07pm
425
EX-2.1
w1ruhc0x3pfxejmj
29 Jun 23
Business combination disclosure
9:10am